A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells()

To make sure that novel human cell-based products contribute to human health care, it is essential that, based on sound science at present, suitable measures be taken by the manufacturers and regulatory authorities on applying these products to the treatment of patients by taking into account specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayakawa, Takao, Aoi, Takashi, Umezawa, Akihiro, Ozawa, Keiya, Sato, Yoji, Sawa, Yoshiki, Matsuyama, Akifumi, Yamanaka, Shinya, Yamato, Masayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society for Regenerative Medicine 2015
Materias:
Special Article: Regulatory science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581870/
https://www.ncbi.nlm.nih.gov/pubmed/31245460
http://dx.doi.org/10.1016/j.reth.2015.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581870/
https://www.ncbi.nlm.nih.gov/pubmed/31245460
http://dx.doi.org/10.1016/j.reth.2015.05.002

Ejemplares similares